Dorte Linnemann

2.4k total citations
60 papers, 1.9k citations indexed

About

Dorte Linnemann is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Dorte Linnemann has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 21 papers in Oncology and 13 papers in Surgery. Recurrent topics in Dorte Linnemann's work include Neurogenesis and neuroplasticity mechanisms (8 papers), Gastric Cancer Management and Outcomes (7 papers) and Genetic factors in colorectal cancer (7 papers). Dorte Linnemann is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (8 papers), Gastric Cancer Management and Outcomes (7 papers) and Genetic factors in colorectal cancer (7 papers). Dorte Linnemann collaborates with scholars based in Denmark, Romania and Germany. Dorte Linnemann's co-authors include Elisabeth Bock, Estrid Høgdall, Ole Nybroe, Joan M. Lyles, Henrik Jahnsen, Lars Christian B. Rønn, Eva Serup‐Hansen, Hanne Havsteen, Poul Geertsen and Jacob Rosenberg and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Dorte Linnemann

60 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dorte Linnemann Denmark 25 715 588 530 417 301 60 1.9k
Gregory L. Bennett United States 17 943 1.3× 273 0.5× 186 0.4× 494 1.2× 171 0.6× 21 2.3k
Eike Gallmeier Germany 25 1.2k 1.7× 958 1.6× 197 0.4× 416 1.0× 203 0.7× 61 2.6k
Christopher B. Chambers United States 18 1.1k 1.6× 420 0.7× 391 0.7× 156 0.4× 146 0.5× 51 2.1k
Tara Karnezis Australia 24 1.1k 1.6× 1.4k 2.4× 355 0.7× 296 0.7× 159 0.5× 35 2.6k
Dara Kallop United States 13 1.2k 1.7× 579 1.0× 155 0.3× 278 0.7× 210 0.7× 13 2.1k
Thomas D. Arnold United States 20 661 0.9× 256 0.4× 212 0.4× 158 0.4× 287 1.0× 30 2.0k
Barbara A. Christy United States 23 1.4k 2.0× 435 0.7× 323 0.6× 375 0.9× 132 0.4× 47 2.4k
Maya H. Nisancioglu Sweden 6 890 1.2× 316 0.5× 110 0.2× 280 0.7× 179 0.6× 7 2.4k
Giuseppe Lamorte Italy 22 1.5k 2.1× 804 1.4× 117 0.2× 262 0.6× 144 0.5× 44 2.5k
Candace L. Kerr United States 27 851 1.2× 161 0.3× 183 0.3× 176 0.4× 252 0.8× 53 1.7k

Countries citing papers authored by Dorte Linnemann

Since Specialization
Citations

This map shows the geographic impact of Dorte Linnemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorte Linnemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorte Linnemann more than expected).

Fields of papers citing papers by Dorte Linnemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorte Linnemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorte Linnemann. The network helps show where Dorte Linnemann may publish in the future.

Co-authorship network of co-authors of Dorte Linnemann

This figure shows the co-authorship network connecting the top 25 collaborators of Dorte Linnemann. A scholar is included among the top collaborators of Dorte Linnemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorte Linnemann. Dorte Linnemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Njor, Sisse Helle, Berit Andersen, Lennart Friis‐Hansen, et al.. (2021). The optimal cut‐off value in fit‐based colorectal cancer screening: An observational study. Cancer Medicine. 10(5). 1872–1879. 21 indexed citations
2.
O’Rourke, Colm J., Christian Dehlendorff, Ole Larsen, et al.. (2020). Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers. Clinical Cancer Research. 26(21). 5655–5667. 21 indexed citations
3.
Palshof, Jesper Andreas, Estrid Høgdall, Tim Svenstrup Poulsen, et al.. (2020). ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer. International Journal of Molecular Sciences. 21(14). 5027–5027. 8 indexed citations
4.
Larsen, Ole, et al.. (2019). Exome sequencing of 22 genes using tissue from patients with biliary tract cancer. Apmis. 128(1). 3–9. 3 indexed citations
5.
Palshof, Jesper Andreas, Estrid Høgdall, Tim Svenstrup Poulsen, et al.. (2017). Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer. BMC Cancer. 17(1). 48–48. 17 indexed citations
6.
Larsen, Finn Ole, Benny Vittrup Jensen, Kirsten Vistisen, et al.. (2016). Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer. Clinical Colorectal Cancer. 16(2). e7–e14. 9 indexed citations
7.
Espersen, Maiken Lise Marcker, Dorte Linnemann, Ib Jarle Christensen, et al.. (2016). SOX9 expression predicts relapse of stage II colon cancer patients. Human Pathology. 52. 38–46. 21 indexed citations
8.
Gilbert, Duncan C., Eva Serup‐Hansen, Dorte Linnemann, et al.. (2016). Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer. British Journal of Cancer. 114(2). 134–137. 62 indexed citations
10.
Klein, Mads, Dorte Linnemann, & Jacob Rosenberg. (2011). Non-steroidal anti-inflammatory drug–induced colopathy. BMJ Case Reports. 2011. bcr1020103436–bcr1020103436. 15 indexed citations
11.
Eriksen, Jens, Jakob Ilsted Bech, Dorte Linnemann, & Jacob Rosenberg. (2008). Laparoscopic intraperitoneal mesh fixation with fibrin sealant (Tisseel®) vs. titanium tacks: a randomised controlled experimental study in pigs. Hernia. 12(5). 483–491. 64 indexed citations
12.
Rønn, Lars Christian B., Elisabeth Bock, Dorte Linnemann, & Henrik Jahnsen. (1995). NCAM-antibodies modulate induction of long-term potentiation in rat hippocampal CA1. Brain Research. 677(1). 145–151. 143 indexed citations
13.
Gegelashvili, Georgi, Arne Schousboe, & Dorte Linnemann. (1994). Expression of amyloid precursor protein (APP) in rat brain and cultured neural cells. International Journal of Developmental Neuroscience. 12(8). 703–708. 11 indexed citations
14.
Linnemann, Dorte. (1994). Reexpression of the neural cell adhesion molecule (NCAM) on cardiac myocytes in aging rat heart. Acta Histochemica. 96(4). 349–354. 1 indexed citations
15.
Linnemann, Dorte, et al.. (1993). Expression of NCAM mRNA and polypeptides in aging rat brain. International Journal of Developmental Neuroscience. 11(1). 71–81. 24 indexed citations
16.
Andersson, Anna‐Maria, et al.. (1993). Age-related changes in expression of neural cell adhesion molecule (NCAM) in heart: a comparative study of newborn, adult and aged rats.. PubMed. 61(1). 100–7. 10 indexed citations
17.
Blom, Nikolaj & Dorte Linnemann. (1992). [Alzheimer's dementia and amyloid precursor-protein].. PubMed. 154(15). 1010–5. 1 indexed citations
18.
Nybroe, Ole, Dorte Linnemann, & Elisabeth Bock. (1988). NCAM biosynthesis in brain. Neurochemistry International. 12(3). 251–262. 63 indexed citations
19.
Linnemann, Dorte, et al.. (1987). Characterization of the biosynthesis, membrane association and function of the cell adhesion molecule L1. Neurochemistry International. 10(1). 113–120. 13 indexed citations
20.
Bock, Elisabeth, et al.. (1987). Characterization of soluble forms of NCAM. FEBS Letters. 225(1-2). 33–36. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026